A citation-based method for searching scientific literature

Tamiem Adam, Therese M Becker, Wei Chua, Victoria Bray, Tara L Roberts. Cancers (Basel) 2021
Times Cited: 4







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The immune contexture in cancer prognosis and treatment.
Wolf H Fridman, Laurence Zitvogel, Catherine Sautès-Fridman, Guido Kroemer. Nat Rev Clin Oncol 2017
762
50


Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab.
Alexander Martens, Kilian Wistuba-Hamprecht, Marnix Geukes Foppen, Jianda Yuan, Michael A Postow, Phillip Wong, Emanuela Romano, Amir Khammari, Brigitte Dreno, Mariaelena Capone,[...]. Clin Cancer Res 2016
326
25

Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial.
Alexander M M Eggermont, Christian U Blank, Mario Mandala, Georgina V Long, Victoria G Atkinson, Stéphane Dalle, Andrew M Haydon, Andrey Meshcheryakov, Adnan Khattak, Matteo S Carlino,[...]. J Clin Oncol 2020
57
25

Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma.
Veronica Huber, Viviana Vallacchi, Viktor Fleming, Xiaoying Hu, Agata Cova, Matteo Dugo, Eriomina Shahaj, Roberta Sulsenti, Elisabetta Vergani, Paola Filipazzi,[...]. J Clin Invest 2018
101
25


Myeloid-derived suppressor cells as regulators of the immune system.
Dmitry I Gabrilovich, Srinivas Nagaraj. Nat Rev Immunol 2009
25

TRF2 positively regulates SULF2 expression increasing VEGF-A release and activity in tumor microenvironment.
Pasquale Zizza, Roberto Dinami, Manuela Porru, Chiara Cingolani, Erica Salvati, Angela Rizzo, Carmen D'Angelo, Eleonora Petti, Carla Azzurra Amoreo, Marcella Mottolese,[...]. Nucleic Acids Res 2019
20
25

The prognostic significance of VISTA and CD33-positive myeloid cells in cutaneous melanoma and their relationship with PD-1 expression.
Jae Won Choi, Young Jae Kim, Kyung A Yun, Chong Hyun Won, Mi Woo Lee, Jee Ho Choi, Sung Eun Chang, Woo Jin Lee. Sci Rep 2020
12
25

Molecular and Immune Biomarkers for Cutaneous Melanoma: Current Status and Future Prospects.
Lorenzo Pilla, Andrea Alberti, Pierluigi Di Mauro, Maria Gemelli, Viola Cogliati, Marina Elena Cazzaniga, Paolo Bidoli, Cristina Maccalli. Cancers (Basel) 2020
3
33

Circulating Cytokines Predict Immune-Related Toxicity in Melanoma Patients Receiving Anti-PD-1-Based Immunotherapy.
Su Y Lim, Jenny H Lee, Tuba N Gide, Alexander M Menzies, Alexander Guminski, Matteo S Carlino, Edmond J Breen, Jean Y H Yang, Shila Ghazanfar, Richard F Kefford,[...]. Clin Cancer Res 2019
108
25

Diagnostic value of immunohistochemistry for the detection of the BRAF(V600E) mutation in papillary thyroid carcinoma: comparative analysis with three DNA-based assays.
Marius I Ilie, Sandra Lassalle, Elodie Long-Mira, Christelle Bonnetaud, Olivier Bordone, Virginie Lespinet, Aude Lamy, Jean-Christophe Sabourin, Juliette Haudebourg, Catherine Butori,[...]. Thyroid 2014
46
25

Multiplexed Immunohistochemistry for Molecular and Immune Profiling in Lung Cancer-Just About Ready for Prime-Time?
Paul Hofman, Cécile Badoual, Fiona Henderson, Léa Berland, Marame Hamila, Elodie Long-Mira, Sandra Lassalle, Hélène Roussel, Véronique Hofman, Eric Tartour,[...]. Cancers (Basel) 2019
45
25

TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells.
Annamaria Biroccio, Julien Cherfils-Vicini, Adeline Augereau, Sébastien Pinte, Serge Bauwens, Jing Ye, Thomas Simonet, Béatrice Horard, Karine Jamet, Ludovic Cervera,[...]. Nat Cell Biol 2013
81
25

Telomere dysfunction and evolution of intestinal carcinoma in mice and humans.
K L Rudolph, M Millard, M W Bosenberg, R A DePinho. Nat Genet 2001
403
25

Expression of mRNAs for telomeric repeat binding factor (TRF)-1 and TRF2 in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
Kuniaki Nakanishi, Toshiaki Kawai, Fumiyuki Kumaki, Sadayuki Hiroi, Makio Mukai, Eiji Ikeda, Catherine Elaine Koering, Eric Gilson. Clin Cancer Res 2003
74
25

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.
Suzanne L Topalian, F Stephen Hodi, Julie R Brahmer, Scott N Gettinger, David C Smith, David F McDermott, John D Powderly, Richard D Carvajal, Jeffrey A Sosman, Michael B Atkins,[...]. N Engl J Med 2012
25

Clinical Significance of Circulating CD33+CD11b+HLA-DR- Myeloid Cells in Patients with Stage IV Melanoma Treated with Ipilimumab.
Moshe Sade-Feldman, Julia Kanterman, Yair Klieger, Eliran Ish-Shalom, Mizrahi Olga, Amijai Saragovi, Hani Shtainberg, Michal Lotem, Michal Baniyash. Clin Cancer Res 2016
111
25

The Telomeric Protein TRF2 Regulates Angiogenesis by Binding and Activating the PDGFRβ Promoter.
Mounir El Maï, Kay-Dietrich Wagner, Jean-François Michiels, Damien Ambrosetti, Arnaud Borderie, Sandrine Destree, Valerie Renault, Nadir Djerbi, Marie-Josèphe Giraud-Panis, Eric Gilson,[...]. Cell Rep 2014
48
25

Pretreatment Innate Cell Populations and CD4 T Cells in Blood Are Associated With Response to Immune Checkpoint Blockade in Melanoma Patients.
Mehdi R Pirozyan, Helen M McGuire, Abdullah Al Emran, Hsin-Yi Tseng, Jessamy C Tiffen, Jenny H Lee, Matteo S Carlino, Alexander M Menzies, Georgina V Long, Richard A Scolyer,[...]. Front Immunol 2020
9
25

Biomarkers of response to immune checkpoint blockade in cancer treatment.
Takeo Fujii, Aung Naing, Christian Rolfo, Joud Hajjar. Crit Rev Oncol Hematol 2018
34
25

A subpopulation that may correspond to granulocytic myeloid-derived suppressor cells reflects the clinical stage and progression of cutaneous melanoma.
Ivan Stanojevic, Karolina Miller, Lidija Kandolf-Sekulovic, Zeljko Mijuskovic, Lidija Zolotarevski, Milena Jovic, Milomir Gacevic, Mirjana Djukic, Nebojsa Arsenijevic, Danilo Vojvodic. Int Immunol 2016
16
25

A DNA damage checkpoint response in telomere-initiated senescence.
Fabrizio d'Adda di Fagagna, Philip M Reaper, Lorena Clay-Farrace, Heike Fiegler, Philippa Carr, Thomas Von Zglinicki, Gabriele Saretzki, Nigel P Carter, Stephen P Jackson. Nature 2003
25

Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression.
Christopher Groth, Xiaoying Hu, Rebekka Weber, Viktor Fleming, Peter Altevogt, Jochen Utikal, Viktor Umansky. Br J Cancer 2019
181
25

Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors.
Rilan Bai, Zheng Lv, Dongsheng Xu, Jiuwei Cui. Biomark Res 2020
51
25

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
Jedd D Wolchok, Vanna Chiarion-Sileni, Rene Gonzalez, Piotr Rutkowski, Jean-Jacques Grob, C Lance Cowey, Christopher D Lao, John Wagstaff, Dirk Schadendorf, Pier F Ferrucci,[...]. N Engl J Med 2017
25

Neutrophils as myeloid-derived suppressor cells.
Cathelijn E M Aarts, Taco W Kuijpers. Eur J Clin Invest 2018
37
25

TRF2 inhibition triggers apoptosis and reduces tumourigenicity of human melanoma cells.
Annamaria Biroccio, Angela Rizzo, Raffaella Elli, Catherine-Elaine Koering, Aurélie Belleville, Barbara Benassi, Carlo Leonetti, Malcolm F G Stevens, Maurizio D'Incalci, Gabriella Zupi,[...]. Eur J Cancer 2006
54
25

A study of CD33 (SIGLEC-3) antigen expression and function on activated human T and NK cells: two isoforms of CD33 are generated by alternative splicing.
Trinidad Hernández-Caselles, María Martínez-Esparza, Ana B Pérez-Oliva, Ana M Quintanilla-Cecconi, Ana García-Alonso, D María Rocío Alvarez-López, Pilar García-Peñarrubia. J Leukoc Biol 2006
79
25

Comprehensive analyses of tumor immunity: implications for cancer immunotherapy.
Bo Li, Eric Severson, Jean-Christophe Pignon, Haoquan Zhao, Taiwen Li, Jesse Novak, Peng Jiang, Hui Shen, Jon C Aster, Scott Rodig,[...]. Genome Biol 2016
727
25

Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences.
Janesh Pillay, Tamar Tak, Vera M Kamp, Leo Koenderman. Cell Mol Life Sci 2013
219
25

Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma.
Antoni Ribas, Omid Hamid, Adil Daud, F Stephen Hodi, Jedd D Wolchok, Richard Kefford, Anthony M Joshua, Amita Patnaik, Wen-Jen Hwu, Jeffrey S Weber,[...]. JAMA 2016
616
25

TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients.
Roberto Dinami, Manuela Porru, Carla Azzurra Amoreo, Isabella Sperduti, Marcella Mottolese, Simonetta Buglioni, Daniele Marinelli, Marcello Maugeri-Saccà, Andrea Sacconi, Giovanni Blandino,[...]. J Exp Clin Cancer Res 2020
7
25

Nivolumab in previously untreated melanoma without BRAF mutation.
Caroline Robert, Georgina V Long, Benjamin Brady, Caroline Dutriaux, Michele Maio, Laurent Mortier, Jessica C Hassel, Piotr Rutkowski, Catriona McNeil, Ewa Kalinka-Warzocha,[...]. N Engl J Med 2015
25

Telomeric localization of TRF2, a novel human telobox protein.
T Bilaud, C Brun, K Ancelin, C E Koering, T Laroche, E Gilson. Nat Genet 1997
374
25

Cancer cells induce immune escape via glycocalyx changes controlled by the telomeric protein TRF2.
Julien Cherfils-Vicini, Charlene Iltis, Ludovic Cervera, Sabrina Pisano, Olivier Croce, Nori Sadouni, Balázs Győrffy, Romy Collet, Valérie M Renault, Martin Rey-Millet,[...]. EMBO J 2019
29
25


High expression of TRF2, SOX10, and CD10 in circulating tumor microemboli detected in metastatic melanoma patients. A potential impact for the assessment of disease aggressiveness.
Elodie Long, Marius Ilie, Coraline Bence, Catherine Butori, Eric Selva, Salomé Lalvée, Christelle Bonnetaud, Gilles Poissonnet, Jean-Philippe Lacour, Philippe Bahadoran,[...]. Cancer Med 2016
28
25


Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2.
D Broccoli, A Smogorzewska, L Chong, T de Lange. Nat Genet 1997
719
25


Elevated TRF2 in advanced breast cancers with short telomeres.
Malissa C Diehl, Michael O Idowu, Katherine N Kimmelshue, Timothy P York, Colleen K Jackson-Cook, Kristi C Turner, Shawn E Holt, Lynne W Elmore. Breast Cancer Res Treat 2011
28
25

Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
Jeffrey E Gershenwald, Richard A Scolyer, Kenneth R Hess, Vernon K Sondak, Georgina V Long, Merrick I Ross, Alexander J Lazar, Mark B Faries, John M Kirkwood, Grant A McArthur,[...]. CA Cancer J Clin 2017
887
25

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
James Larkin, Vanna Chiarion-Sileni, Rene Gonzalez, Jean-Jacques Grob, Piotr Rutkowski, Christopher D Lao, C Lance Cowey, Dirk Schadendorf, John Wagstaff, Reinhard Dummer,[...]. N Engl J Med 2019
950
25

Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology.
Claudia A Dumitru, Katrin Moses, Sokratis Trellakis, Stephan Lang, Sven Brandau. Cancer Immunol Immunother 2012
229
25

Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients.
Kimberly R Jordan, Rodabe N Amaria, Oscar Ramirez, Eryn B Callihan, Dexiang Gao, Michelle Borakove, Elizabeth Manthey, Virginia F Borges, Martin D McCarter. Cancer Immunol Immunother 2013
84
25


Integrated molecular analysis of clear-cell renal cell carcinoma.
Yusuke Sato, Tetsuichi Yoshizato, Yuichi Shiraishi, Shigekatsu Maekawa, Yusuke Okuno, Takumi Kamura, Teppei Shimamura, Aiko Sato-Otsubo, Genta Nagae, Hiromichi Suzuki,[...]. Nat Genet 2013
639
25


Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal.
Samra Turajlic, Hang Xu, Kevin Litchfield, Andrew Rowan, Tim Chambers, Jose I Lopez, David Nicol, Tim O'Brien, James Larkin, Stuart Horswell,[...]. Cell 2018
298
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.